Skip to main content

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

AVBP holding history

ArriVent BioPharma, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVBP overviewAll 13F holders of AVBPFull Q2 2026 holdings

Shares (Q2 2026)
125,000
Value
$4.34M
% of portfolio
0.2%
Quarters held
3
Since Q4 2025
Holdings of AVBP by Affinity Asset Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026125,000$4.34M0.2%−50,000−28.6%ReducedHolders
Q1 2026175,000$4.04M0.2%+25,000+16.7%AddedHolders
Q4 2025150,000$3.02M0.2%+150,000NewHolders